PAREXEL offers a broad range of services - from strategy to commercialization - to the biopharmaceutical industry. With extensive experience in biopharmaceutical product development and regulatory affairs, our team of professionals can help accelerate the transition from Drug Discovery to Clinical Proof-of-Concept through to Clinical Development. Partnering with client senior management provides the opportunity to integrate drug development and commercialization strategy with business objectives.
For small and medium companies requiring deep capabilities and experience in global bio/pharmaceutical and medical device development and commercialization, PAREXEL International helps develop the product with the right quality standards for the right patient population, and successful interaction with regulatory agencies, through our combined scientific, clinical and regulatory expertise.
We are a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.